Shibasaki, Masahiro <br/><br/>
Implication of mGlu5 receptor in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem.  [electronic resource] 

 -  European journal of pharmacology  Sep 2014 
 - 360-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2014.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 4--metabolism<br/>Cyclic AMP Response Element-Binding Protein--metabolism<br/>GABA-A Receptor Agonists--pharmacology<br/>Glutamate Decarboxylase--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Morphine--pharmacology<br/>Motor Activity--drug effects<br/>Phospholipase C beta--metabolism<br/>Phosphoproteins--metabolism<br/>Prosencephalon--drug effects<br/>Pyridines--pharmacology<br/>RNA, Messenger--genetics<br/>Receptors, GABA-A--metabolism<br/>Receptors, Metabotropic Glutamate--antagonists & inhibitors<br/>Receptors, N-Methyl-D-Aspartate--metabolism<br/>Receptors, Opioid, mu--genetics<br/>STAT3 Transcription Factor--metabolism<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism<br/>Zolpidem